Uncategorized

  • From DNA Code to Chemistry

    Sumon Pratihar, Eric T. Kool and his team from Stanford University just published new paper in ๐˜ˆ๐˜ฏ๐˜จ๐˜ฆ๐˜ธ๐˜ข๐˜ฏ๐˜ฅ๐˜ต๐˜ฆ ๐˜Š๐˜ฉ๐˜ฆ๐˜ฎ๐˜ช๐˜ฆ, unlocking a new way of selective RNA modification: “๐˜š๐˜ฆ๐˜ฒ๐˜ถ๐˜ฆ๐˜ฏ๐˜ค๐˜ฆ-๐˜š๐˜ฑ๐˜ฆ๐˜ค๐˜ช๐˜ง๐˜ช๐˜ค ๐˜๐˜ฏ๐˜ด๐˜ต๐˜ข๐˜ญ๐˜ญ๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ฐ๐˜ง ๐˜ˆ๐˜ณ๐˜บ๐˜ญ ๐˜Ž๐˜ณ๐˜ฐ๐˜ถ๐˜ฑ๐˜ด ๐˜ช๐˜ฏ ๐˜™๐˜•๐˜ˆ ๐˜ท๐˜ช๐˜ข ๐˜‹๐˜•๐˜ˆ-๐˜Š๐˜ข๐˜ต๐˜ข๐˜ญ๐˜บ๐˜ด๐˜ต ๐˜Š๐˜ฐ๐˜ฏ๐˜ซ๐˜ถ๐˜จ๐˜ข๐˜ต๐˜ฆ๐˜ด” Key innovationDNA-directed approach that utilizes a DNA oligonucleotide carrying a nucleophilic amine to promote site-selective SNAr reaction at RNA…

  • Why Would You Biotinylate Ubiquitin?

    E-STUB: A Precision Tool for Mapping E3 Ligase Substrates In march 2025, colleagues from Dana Faber and The Broad Institute published in ๐˜•๐˜ข๐˜ต๐˜ถ๐˜ณ๐˜ฆ ๐˜Š๐˜ฉ๐˜ฆ๐˜ฎ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜‰๐˜ช๐˜ฐ๐˜ญ๐˜ฐ๐˜จ๐˜บ: “๐˜œ๐˜ฃ๐˜ช๐˜ฒ๐˜ถ๐˜ช๐˜ต๐˜ช๐˜ฏ-๐˜ด๐˜ฑ๐˜ฆ๐˜ค๐˜ช๐˜ง๐˜ช๐˜ค ๐˜ฑ๐˜ณ๐˜ฐ๐˜น๐˜ช๐˜ฎ๐˜ช๐˜ต๐˜บ ๐˜ญ๐˜ข๐˜ฃ๐˜ฆ๐˜ญ๐˜ช๐˜ฏ๐˜จ ๐˜ง๐˜ฐ๐˜ณ ๐˜ต๐˜ฉ๐˜ฆ ๐˜ช๐˜ฅ๐˜ฆ๐˜ฏ๐˜ต๐˜ช๐˜ง๐˜ช๐˜ค๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ฐ๐˜ง ๐˜Œ3 ๐˜ญ๐˜ช๐˜จ๐˜ข๐˜ด๐˜ฆ ๐˜ด๐˜ถ๐˜ฃ๐˜ด๐˜ต๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜ด” How it worksE-STUB (E3-Substrate Tagging by Ubiquitin Biotinylation) combines the principles of proximity labeling with the functional specificity of ubiquitin…

  • Think spยณ Rich!

    Top notch medchem building blocks got unlocked. Chemists from Enamine Ltd. published a robust route to saturated azabicyclic scaffolds (Angewandte Chemie): “๐˜‰๐˜ช๐˜ค๐˜บ๐˜ค๐˜ญ๐˜ช๐˜ค ๐˜๐˜ด๐˜ฐ๐˜ด๐˜ต๐˜ฆ๐˜ณ๐˜ฆ๐˜ด ๐˜ฐ๐˜ง ๐˜—๐˜บ๐˜ณ๐˜ช๐˜ฅ๐˜ช๐˜ฏ๐˜ฆ/๐˜—๐˜ช๐˜ฑ๐˜ฆ๐˜ณ๐˜ช๐˜ฅ๐˜ช๐˜ฏ๐˜ฆ: ๐˜๐˜ณ๐˜ฐ๐˜ฎ ๐˜š๐˜บ๐˜ฏ๐˜ต๐˜ฉ๐˜ฆ๐˜ด๐˜ช๐˜ด ๐˜ต๐˜ฐ ๐˜ˆ๐˜ฑ๐˜ฑ๐˜ญ๐˜ช๐˜ค๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ด” Key innovationKOtBu/Iโ‚‚/COโ‚‚-mediated cyclizationย of cyclic alkenyl amines, delivering:โœ”๏ธ 2-azabicyclo[2.2.2]octanes (35-73% yield)โœ”๏ธ 2-azabicyclo[3.2.1]octaneย (69% yield)โœ”๏ธ 2-azabicyclo[2.2.1]heptanesย (75-85% yield)โœ”๏ธ 7-azabicyclo[2.2.1]heptaneย (70% yield)โœ”๏ธ 2-azabicyclo[3.1.1]heptanesย (62-73% yield)โœ”๏ธ 2-azabicyclo[2.1.1]hexanesย (52-90% yield) โœ… 52โ€“90% yieldโœ… Scales up to…

  • A Unified Platform for Nucleoside Analog Synthesis

    Why nucleoside analogs matter and why they’re hard to make Nucleoside analogs (NAs) are among the most successful drug classes in medicine, with more than 30 currently approved for treating viral infections such as HIV/AIDS and hepatitis, as well as certain cancers. These synthetic mimics of natural nucleosides act as antimetabolites through diverse mechanisms: inhibiting…

  • BRET: State-Of-The-Art Technology for Target Engagement in Living Cells

    Direct monitoring of a binding interaction between biomolecules and their ligands is one of the cornerstones of early drug discovery, chemical biology and related disciplines. Assays that allow (semi)-quantitative measurements of the direct binding event, so-called target engagement (TE), became indispensable components of workflows for development or characterization of small molecules, peptides, antibodies, oligonucleotides and…

  • Breakthrough in Crossโ€‘Coupling Chemistry

    Wang et al. report a new copper-catalyzed methodology for C(spยณ)-N cross-coupling of unactivated alkyl halides with diverse nucleophiles under thermal conditions (JACS): “๐˜ˆ ๐˜Ž๐˜ฆ๐˜ฏ๐˜ฆ๐˜ณ๐˜ข๐˜ญ ๐˜Š๐˜ฐ๐˜ฑ๐˜ฑ๐˜ฆ๐˜ณ-๐˜Š๐˜ข๐˜ต๐˜ข๐˜ญ๐˜บ๐˜ป๐˜ฆ๐˜ฅ ๐˜™๐˜ข๐˜ฅ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜Š๐˜ณ๐˜ฐ๐˜ด๐˜ด-๐˜Š๐˜ฐ๐˜ถ๐˜ฑ๐˜ญ๐˜ช๐˜ฏ๐˜จ ๐˜ฐ๐˜ง ๐˜œ๐˜ฏ๐˜ข๐˜ค๐˜ต๐˜ช๐˜ท๐˜ข๐˜ต๐˜ฆ๐˜ฅ ๐˜ˆ๐˜ญ๐˜ฌ๐˜บ๐˜ญ ๐˜๐˜ข๐˜ญ๐˜ช๐˜ฅ๐˜ฆ๐˜ด” (Colleagues doing automated or high-throughput synthesis will love this) Key InnovationThe success of this methodology relies on the use of anionic N,N,N-ligands to enhance…

  • Curious How Drug Discovery Can Be Accelerated by DELโ€‘ML?

    Then I would like to invite you to read our paper in RSC Chem. Biol. which also represents my first corresponding authorship: “๐˜‹๐˜ช๐˜ด๐˜ค๐˜ฐ๐˜ท๐˜ฆ๐˜ณ๐˜บ ๐˜ฐ๐˜ง ๐˜ข๐˜ฏ ๐˜ฆ๐˜น๐˜ฒ๐˜ถ๐˜ช๐˜ด๐˜ช๐˜ต๐˜ฆ๐˜ญ๐˜บ ๐˜ด๐˜ฆ๐˜ญ๐˜ฆ๐˜ค๐˜ต๐˜ช๐˜ท๐˜ฆ ๐˜ž๐˜‹๐˜™5 ๐˜ค๐˜ฉ๐˜ฆ๐˜ฎ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜ฑ๐˜ณ๐˜ฐ๐˜ฃ๐˜ฆ ๐˜ข๐˜ค๐˜ค๐˜ฆ๐˜ญ๐˜ฆ๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜ฅ ๐˜ฃ๐˜บ ๐˜ข ๐˜ฉ๐˜ช๐˜จ๐˜ฉ-๐˜ฒ๐˜ถ๐˜ข๐˜ญ๐˜ช๐˜ต๐˜บ ๐˜‹๐˜Œ๐˜“โ€“๐˜”๐˜“ ๐˜๐˜ช๐˜ต” (DEL-ML = DNA Encoded Library + Machine Learning) Highlightsโœ… We demonstrate power of DEL-ML and how it can accelerate…

  • Editing Protein Backbone Inside Living Cells

    For decades, creating proteins with extended backbones (ฮฒ, ฮณ, ฮด-amino acids) inside living cells has been challenging. Researchers at University of California, Berkeley (Alanna Schepartz, Leah Roe), Yale University, Amgen and collaborators developedย BEAR reactionsย to address this challenge. ๐–๐ก๐ฒ ๐๐จ๐ž๐ฌ ๐ญ๐ก๐ข๐ฌ ๐ฆ๐š๐ญ๐ญ๐ž๐ซ?โ†’ Extension of backbone can lead to improved phys-chem propertiesโ†’ Better stability and resistance to…

  • Drugging the “Undruggable” ๐Ÿ’Š

    ๐Ÿ”ธ 50 new CRBN neosubstrates๐Ÿ”ธ 3 bona fide degraders๐Ÿ”ธ MS-proteomic platform expanding druggable proteome All of this packed in single paperโ— by colleagues from NEOsphere Biotechnologies GmbH, ICR Centre for Protein Degradation and St. Jude Children’s Research Hospital – ALSAC Additional highlightsโœ… Screened 100 CRBN-binders across two cancer cell linesโœ… Identified 50 novel CRBN neosubstratesโ—โœ……